You are currently viewing a new version of our website. To view the old version click .

Advances in Head and Neck Cancer

This special issue belongs to the section “Molecular and Translational Medicine“.

Special Issue Information

Dear Colleagues,

This Special Issue, "Advances in Head and Neck Cancer", will provide a thorough exploration of the latest developments in the diagnosis, treatment, and comprehensive management of head and neck cancers. This Special Issue will delve into innovative therapeutic approaches, such as personalized medicine, immunotherapy, and novel molecular targets, with a special emphasis on advanced radiotherapy techniques, including dose escalation, dose de-escalation, VMAT, SBRT, image guidance, and particle therapy, as well as the incorporation of minimally invasive surgical methods.

In addition to innovative treatments, this Special Issue will focus on the use of biomarkers to predict treatment responses and understand disease progression.

By featuring a diverse range of expert perspectives, this Special Issue will provide invaluable insights for clinicians, researchers, and healthcare professionals committed to advancing treatment outcomes and comprehensive care for patients with head and neck cancer.

Dr. Yu-Ming Wang
Dr. Sheng-Dean Luo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • modern therapeutic approach
  • nasopharyngeal carcinoma
  • head and neck cancer
  • particle therapy
  • cancer survivorship
  • sinonasal cancer

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomedicines - ISSN 2227-9059